Lifeward (LFWD) Total Current Liabilities (2014 - 2026)
Lifeward (LFWD) reported Total Current Liabilities of $10.6 million for Q1 2026, up 17.24% on a YoY basis from $9.1 million in Q1 2025, and down 11.66% sequentially from $12.0 million in Q4 2025.
Lifeward (LFWD) Total Current Liabilities (2014 - 2026) Analysis & Trends
Lifeward (LFWD) has 13 years of Total Current Liabilities data on file, last reported at $10.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 17.24% year-over-year to $10.6 million; the trailing twelve-month figure through Mar 2026 stood at $10.6 million (up 17.24% YoY), and the FY2025 full-year result was $12.0 million, up 17.74% from the prior year.
- Total Current Liabilities fell to $10.6 million in Q1 2026, from $12.0 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $12.8 million in Q3 2023 to a low of $3.6 million in Q1 2022.
- A 5-year average of $8.3 million and a median of $9.7 million in 2024 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities soared 203.65% in 2023 and slipped 24.64% in 2024, its largest moves.
- Tracing LFWD's Total Current Liabilities over 5 years: stood at $4.8 million in 2022, then surged by 146.65% to $11.8 million in 2023, then decreased by 13.31% to $10.2 million in 2024, then increased by 17.74% to $12.0 million in 2025, then dropped by 11.66% to $10.6 million in 2026.
- Business Quant data shows LFWD's Total Current Liabilities at $10.6 million in Q1 2026, $12.0 million in Q4 2025, and $9.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn | 10.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.64 Mn |
| Dec 31, 2025 | 12.04 Mn |
| Sep 30, 2025 | 9.05 Mn |
| Jun 30, 2025 | 10.36 Mn |
| Mar 31, 2025 | 9.07 Mn |
| Dec 31, 2024 | 10.23 Mn |
| Sep 30, 2024 | 9.66 Mn |
| Jun 30, 2024 | 9.97 Mn |
| Mar 31, 2024 | 10.09 Mn |
| Dec 31, 2023 | 11.80 Mn |
| Sep 30, 2023 | 12.81 Mn |
| Jun 30, 2023 | 5.44 Mn |
| Mar 31, 2023 | 3.88 Mn |
| Dec 31, 2022 | 4.78 Mn |
| Sep 30, 2022 | 4.22 Mn |
| Jun 30, 2022 | 3.80 Mn |
| Mar 31, 2022 | 3.62 Mn |
| Dec 31, 2021 | 4.04 Mn |
| Sep 30, 2021 | 4.38 Mn |
| Jun 30, 2021 | 4.20 Mn |